Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Tetrabutylammonium Fluoride | HCID 2724141 | — |
| Reactant | 1,4-Dioxane hydrochloride | HCID 20443148 | — |
| Reactant | HCID 89924514 | HCID 89924514 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 89924391 | HCID 89924391 | 33% |
Reaction Steps
Tetrabutylammonium fluoride (56 mg; 0.21 mmol; 2.0 eq.) was added to a solution of 4-(4-{2-[3-(1-Trimethylsilanylmethyl-1H-[1,2,3]triazol-4-yl)-phenyl]-pyrimidin-5-yl}-pyrazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester (60 mg; 0.11 mmol; 1.0 eq.) in THF (1 mL) and the reaction mixture was stirred at RT for 2 h. It was then diluted with a saturated solution of NaHCO3 and extracted with EtOAc (three times). Combined organic phases were washed with brine, dried over magnesium sulfate, filtered and concentrated. The crude obtained was dissolved in DCM (1 mL) and MeOH (MeOH) and HCl/dioxane (0.4 mL of a 4N solution, 1.6 mmol, 15 eq.) was added. The reaction mixture was stirred at RT for 2 h, concentrated under reduced pressure and purified by autopreparative LC/Ms to give the title compound as a beige solid (15 mg, 33%). 1H NMR (300 MHz, DMSO-d6) δ 9.22 (s, 2H), 9.11 (brs, 1H), 8.94-8.81 (m, 2H), 8.67 (s, 1H), 8.54 (s, 1H), 8.35 (dt, J=7.9 Hz, 1.5 Hz, 1H), 8.22 (s, 1H), 7.96 (dt, J=7.9 Hz, 1.5 Hz, 1H), 7.61 (t, J=7.9 Hz, 1H), 4.61-4.52 (m, 1H), 4.12 (s, 3H), 3.43-3.36 (m, 2H), 3.16-3.06 (m, 2H), 2.28-2.11 (m, 4H). HPLC (Condition A): Rt 2.08 min (purity 98.5%). MS (ESI+): 387.3.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09216991B2 |
|---|
| Source dataset | uspto-grants-2015_12 |
|---|
| ORD ID | ord-05881c8aaa3f47fa8e122bc069da8f28 |
|---|
| Source note | uspto-grants-2015_12 |
|---|